Tyler-Stone Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-127
| Closed | -$6.86K | – | 421 |
|
|
2024
Q2 | $6.86K | Sell |
127
-100
| -44% | -$5.4K | ﹤0.01% | 688 |
|
|
2024
Q1 | $15.5K | Hold |
227
| – | – | 0.01% | 559 |
|
|
2023
Q4 | $14.2K | Hold |
227
| – | – | 0.01% | 558 |
|
|
2023
Q3 | $10K | Hold |
227
| – | – | 0.01% | 599 |
|
|
2023
Q2 | $13K | Buy |
+227
| New | +$13K | 0.01% | 544 |
|
|
2022
Q4 | $9K | Hold |
227
| – | – | 0.01% | 563 |
|
|
2022
Q3 | $15K | Hold |
227
| – | – | 0.01% | 470 |
|
|
2022
Q2 | $14K | Buy |
227
+27
| +14% | +$1.67K | 0.01% | 499 |
|
|
2022
Q1 | $13K | Hold |
200
| – | – | 0.01% | 520 |
|
|
2021
Q4 | $15K | Buy |
+200
| New | +$15K | 0.01% | 520 |
|